Several studies [119,120,121,122] have reported a significant increase in circulating TF-expressing EVs that correlated with D-dimer levels, von Willebrand Factor, circulating leukocytes, and inflammatory markers, assuming the contribution of TF-EVs in disease determining severity and thrombosis in COVID-19 patients. This evidence concerns the gene TF and COVID-19.